GCL
RNAM

Glazer Capital LLC’s Avidity Biosciences RNAM Stock Holding History

Glazer Capital LLC’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,722
Closed -$167K – 520
2025
Q4 		$167K Buy
+5,722
New +$370K ﹤0.01% 265

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Glazer Capital LLC's RNAM Position: Q1 2026 in Review

Glazer Capital LLC sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 2,467,139 shares — an estimated $178M sold.

Glazer Capital LLC first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $178M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Glazer Capital LLC reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Glazer Capital LLC sold 2,467,139 Avidity Biosciences shares in Q1 2026, an estimated $178M.
  • Glazer Capital LLC first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • Glazer Capital LLC's Avidity Biosciences position peaked at $178M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Glazer Capital LLC's 13F filing for Q1 2026, filed 14 May 2026.